DHT-OVA
DHT-OVA is a conjugate of DHT (Dihydrotestosterone) and OVA peptide. By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt linear epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
Para uso exclusivo en investigación. No vendemos a pacientes.
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Chemical Information
-
SMILES
[DHT-OVA]
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Hot Topics
-
All
-
Topics
-
Most Recent
-
Oldest
-
Topics Vaccine Formulation: From Adjuvants to RNA Delivery Systems
Vaccine formulation integrates antigens, adjuvants, and delivery systems to enhance immunogenicity and shape the magnitude, breadth, and durability of immune responses.
2026-06-18
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)